Das Klinikum der Stadt Ludwigshafen ist ein Krankenhaus der Maximalversorgung in Ludwigshafen am Rhein. Klinikträger ist die Stadt Ludwigshafen. Die Rechtsform ist gemeinnützige GmbH. Das Klinikum ist nach der BASF und nach der Stadtverwaltung der drittgrößte Arbeitgeber in Ludwigshafen.

During the past decade, Klinikum Ludwigshafen conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 16 clinical trials were completed, i.e. on average, 37.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 9 clinical trials were completed. i.e. 47.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Ludwigshafen" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Klinikum Ludwigshafen" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored and "IHF GmbH - Institut für Herzinfarktforschung" with 4 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Ludwigshafen" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Charite University, Berlin, Germany" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Ludwigshafen" are "Atrial Fibrillation" (6 trials), "Coronary Artery Disease" (5 trials), "Lymphoma" (5 trials), "Heart Failure" (4 trials) and "Acute Coronary Syndrome" (3 trials). Many other conditions were trialed in "Klinikum Ludwigshafen" in a lesser frequency.

Most popular intervention types in "Klinikum Ludwigshafen" are "Drug" (63 trials), "Device" (16 trials), "Biological" (11 trials), "Procedure" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (4 trials), "filgrastim" (4 trials) and "prednisone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Ludwigshafen" are 93 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Ludwigshafen". undefined are not yet recruiting, 14 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in Klinikum Ludwigshafen, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Ludwigshafen, 5 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 10 trials that are defined as “Not Applicable".

Klinikum Ludwigshafen has several departments that took part in Clinical trials: "Klinikum der Stadt Ludwigshafen; Medizinische Klinik A" - 5 trials, "Department of Anesthesiology and Intensive Care Medicine Klinikum Ludwigshafen" - 2 trials